WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                               September 20, 2005

                           USANA HEALTH SCIENCES, INC.
             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

            Utah                                             87-0500306
(State or other jurisdiction of                     (IRS Employer Identification
    incorporation) Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities
    Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
    Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

Item 8.01     Other Events

On September 20, 2005, USANA Health Sciences, Inc. issued a press release
announcing that it has purchased for cash, a personal care manufacturing
facility in China. A copy of the press release is furnished herewith as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The company will also post this document on its corporate website,
www.usanahealthsciences.com, under the "investors" link.

Item 9.01     Financial Statements and Exhibits (furnished herewith)

              (d)    Exhibits

Exhibit 99.1  Press release issued by USANA Health Sciences, Inc.
              dated September 20, 2005



     Pursuant to the requirements of the Securities Exchange Act of 1934, the
     registrant has duly caused this report to be signed on its behalf by the
     undersigned hereunto duly authorized.

                                      USANA HEALTH SCIENCES, INC.

                                      By: /s/ Gilbert A. Fuller
                                      Gilbert A. Fuller, Chief Financial Officer

Date: September 20, 2005